$VICR

VINCIARELLI PATRIZIO sold $6.4M of VICR

VINCIARELLI PATRIZIO (Chairman & CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $318.88 ($309.15–$350.54, $6.38M total) across 24 trades on 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jul 6, 2026, 5:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 5:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The CEO/Chairman sold 20,000 shares (weighted avg ~$318.88) totaling ~$6.38M, with holdings after the sale reported as 8,348,090 shares; the sale was under a pre-arranged 10b5-1 plan.

02

Market read

Provides a fresh, primary-source datapoint on insider selling activity in VICR, but does not introduce new company fundamentals.

03

What to watch

Traders may over-weight insider sales; without accompanying guidance, contract, or earnings changes, the signal is mostly sentiment/positioning rather than fundamentals.

Relevance 5/10Novelty 5/10Timing: Filed 2026-07-06 for a 2026-07-02 insider sale.

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s CEO/Chairman sold $6.38M of VICR shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is more about optics than new company fundamentals.

Evidence & confidence

The filing provides transaction size, dates, and 10b5-1 context, but no new operational/financial information about VICR.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst described.

None indicated; no regional macro or cross-border event mentioned.

None indicated; no global deal/regulatory action tied to VICR.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider sale disclosure.

  • VINCIARELLI PATRIZIO

    Chairman & CEO and reporting person who executed the open-market sale.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: